| # | Drug | Count |
|---|---|---|
| 0 | RIBAVIRIN | 103 |
| 1 | PEGINTERFERON ALFA-2A | 73 |
| 2 | SOFOSBUVIR | 48 |
| 3 | PREDNISONE | 31 |
| 4 | RITUXIMAB | 30 |
| 5 | TACROLIMUS | 26 |
| 6 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 24 |
| 7 | TACROLIMUS OINTMENT 0.1% | 24 |
| 8 | CYCLOPHOSPHAMIDE | 23 |
| 9 | CYCLOPHOSPHAMIDE FOR INJECTION | 23 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SOFOSBUVIR | 48 | 0.0024 |
| 1 | CYCLOSERINE | 4 | 0.0017 |
| 2 | RIBAVIRIN | 103 | 0.0016 |
| 3 | GLECAPREVIR AND PIBRENTASVIR | 12 | 0.0011 |
| 4 | VELPATASVIR AND SOFOSBUVIR | 13 | 0.0010 |
| 5 | ELBASVIR AND GRAZOPREVIR | 4 | 0.0009 |
| 6 | SOFOSBUVIR, VELPATASVIR, AND VOXILAPREVIR | 1 | 0.0009 |
| 7 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 6 | 0.0007 |
| 8 | PERMETHRIN | 1 | 0.0006 |
| 9 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 4 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 68 | 0.0013 |
| 1 | Nucleoside Analog Antiviral [EPC] | 103 | 0.0012 |
| 2 | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] | 17 | 0.0010 |
| 3 | Hepatitis C Virus NS5A Inhibitor [EPC] | 36 | 0.0007 |
| 4 | Pyrethroid [EPC] | 1 | 0.0006 |
| 5 | Oxazolidinone Antibacterial [EPC] | 7 | 0.0002 |
| 6 | Antimycobacterial [EPC] | 5 | 0.0002 |
| 7 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 14 | 0.0001 |
| 8 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 3 | 0.0001 |
| 9 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 6 | 0.0001 |